The Genome Was the Easy Part
On the challenges and promise of unbiased single-molecule protein sequencing
Through the Longevity Lens
Dispatches on the soon-to-arrive biotech innovations, longevity advancements, and new medical science bringing more life to our years.
Live Last read · last published · next check
Latest posts
The 21st amino-acid
Why the next generation of peptide drugs needs biology to learn a larger alphabet
Engineering Humanity
How gene therapy will shape the future of therapeutics
Now is the time to rethink blood testing… again
Subtitle: And how startups like SiPhox are achieving what Theranos could not
Chasing the Magic Bullet
How next-generation antibody-drug conjugate technologies will redefine cancer and beyond
LongeVC: Five years of betting on the wrong longevity companies (and why that's actually right)
2025 marks five years since LongeVC started investing.